JPRN-UMIN000033294已完成未知
A pilot study of SI-449 adhesion barrier system in patients who are scheduled to undergo temporary ileostomy. - A pilot study of SI-449 adhesion barrier system
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Key exclusion criteria, 1.Patients with history of surgery in the abdominal or pelvic cavity. 2.Patients with having active infection in the abdominal or pelvic cavity. 3.Patients with having active or previous history of peritonitis. 4.Patients with history of hypersensitivity to the investigational device. 5.Patients with a serious hepatic or a serious renal disorder 6.Patients who participated in another clinical study of any drug or medical device within 16 weeks prior to the day of informed consent 7.Any circumstances or conditions, which, in the opinion of the principal investigator or sub-investigator, may affect participation in the study
研究者
相似试验
未知
1 期
A Phase 1b, Open-Label Study to Evaluate the Safety of AMG 479 in Combination with Gemcitabine as First-line Therapy for Metastatic Pancreatic CancerAdvanced solid tumorJPRN-jRCT2080221160Takeda Pharmaceutical Company Limited6
已完成
不适用
A Phase 1b Open-Label Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human anti-TNFa Antibody, in Pediatric Subjects With Moderately to Severely Active Ulcerative ColitisNL-OMON40329Janssen Biologics B.V.4
进行中（未招募）
不适用
A Study to Assess the Safety and Pharmacokinetics (Serum Levels) of Golimumab in Children With Moderately to Severely Active Ulcerative ColitisEUCTR2012-004366-18-BEJanssen Biologics B.V.30
进行中（未招募）
1 期
A Study to Assess the Safety and Pharmacokinetics (Serum Levels) of Golimumab in Children With Moderately to Severely Active Ulcerative Colitislcerative Colitis in pediatric subjectsMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2012-004366-18-ATJanssen Biologics B.V.30
进行中（未招募）
1 期
A Study to Assess the Safety and Pharmacokinetics (Serum Levels) of Golimumab in Children With Moderately to Severely Active Ulcerative ColitisEUCTR2012-004366-18-FRJanssen Biologics B.V.30